Cargando…

Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™

We developed streamlined, automated purification protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) from Escherichia coli, using the ÄKTAxpress™ chromatography system. The automated 2-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludwig, Cornelia, Wear, Martin A., Walkinshaw, Malcolm D.
Formato: Texto
Lenguaje:English
Publicado: Academic Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837147/
https://www.ncbi.nlm.nih.gov/pubmed/19995609
http://dx.doi.org/10.1016/j.pep.2009.12.001
_version_ 1782178775785537536
author Ludwig, Cornelia
Wear, Martin A.
Walkinshaw, Malcolm D.
author_facet Ludwig, Cornelia
Wear, Martin A.
Walkinshaw, Malcolm D.
author_sort Ludwig, Cornelia
collection PubMed
description We developed streamlined, automated purification protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) from Escherichia coli, using the ÄKTAxpress™ chromatography system. The automated 2-step (cation exchange and size exclusion) purification protocol for untagged hCypA results in final purity and yields of ⩾93% and ∼5 mg L(−1) of original cell culture, respectively, in under 12 h, including all primary sample processing and column equilibration steps. The novel automated 4-step (anion exchange, desalt, heparin-affinity and size exclusion, in linear sequence) purification protocol for untagged hPCNA results in final purity and yields of ⩾87% and ∼4 mg L(−1) of original cell culture, respectively, in under 24 h, including all primary sample processing and column equilibration steps. This saves in excess of four full working days when compared to the traditional protocol, producing protein with similar final yield, purity and activity. Furthermore, it limits a time-dependent protein aggregation, a problem with the traditional protocol that results in a loss of final yield. Both automated protocols were developed to use generic commercially available pre-packed columns and automatically prepared minimal buffers, designed to eliminate user and system variations, maximize run reproducibility, standardize yield and purity between batches, increase throughput and reduce user input to a minimum. Both protocols represent robust generic methods for the automated production of untagged hCypA and hPCNA.
format Text
id pubmed-2837147
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-28371472010-03-29 Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™ Ludwig, Cornelia Wear, Martin A. Walkinshaw, Malcolm D. Protein Expr Purif Article We developed streamlined, automated purification protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) from Escherichia coli, using the ÄKTAxpress™ chromatography system. The automated 2-step (cation exchange and size exclusion) purification protocol for untagged hCypA results in final purity and yields of ⩾93% and ∼5 mg L(−1) of original cell culture, respectively, in under 12 h, including all primary sample processing and column equilibration steps. The novel automated 4-step (anion exchange, desalt, heparin-affinity and size exclusion, in linear sequence) purification protocol for untagged hPCNA results in final purity and yields of ⩾87% and ∼4 mg L(−1) of original cell culture, respectively, in under 24 h, including all primary sample processing and column equilibration steps. This saves in excess of four full working days when compared to the traditional protocol, producing protein with similar final yield, purity and activity. Furthermore, it limits a time-dependent protein aggregation, a problem with the traditional protocol that results in a loss of final yield. Both automated protocols were developed to use generic commercially available pre-packed columns and automatically prepared minimal buffers, designed to eliminate user and system variations, maximize run reproducibility, standardize yield and purity between batches, increase throughput and reduce user input to a minimum. Both protocols represent robust generic methods for the automated production of untagged hCypA and hPCNA. Academic Press 2010-05 /pmc/articles/PMC2837147/ /pubmed/19995609 http://dx.doi.org/10.1016/j.pep.2009.12.001 Text en © 2010 Elsevier Inc. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
spellingShingle Article
Ludwig, Cornelia
Wear, Martin A.
Walkinshaw, Malcolm D.
Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™
title Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™
title_full Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™
title_fullStr Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™
title_full_unstemmed Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™
title_short Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™
title_sort streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-a (hcypa) and untagged human proliferating cell nuclear antigen (hpcna) using äktaxpress™
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837147/
https://www.ncbi.nlm.nih.gov/pubmed/19995609
http://dx.doi.org/10.1016/j.pep.2009.12.001
work_keys_str_mv AT ludwigcornelia streamlinedautomatedprotocolsfortheproductionofmilligramquantitiesofuntaggedrecombinanthumancyclophilinahcypaanduntaggedhumanproliferatingcellnuclearantigenhpcnausingaktaxpress
AT wearmartina streamlinedautomatedprotocolsfortheproductionofmilligramquantitiesofuntaggedrecombinanthumancyclophilinahcypaanduntaggedhumanproliferatingcellnuclearantigenhpcnausingaktaxpress
AT walkinshawmalcolmd streamlinedautomatedprotocolsfortheproductionofmilligramquantitiesofuntaggedrecombinanthumancyclophilinahcypaanduntaggedhumanproliferatingcellnuclearantigenhpcnausingaktaxpress